Literature DB >> 23740819

Structural transitions in tau k18 on micelle binding suggest a hierarchy in the efficacy of individual microtubule-binding repeats in filament nucleation.

Patrick Barré1, David Eliezer.   

Abstract

The protein tau is found in an aggregated filamentous state in the intraneuronal paired helical filament deposits characteristic of Alzheimer's disease and other related dementias and mutations in tau protein and mRNA cause frontotemproal dementia. Tau isoforms include a microtubule-binding domain containing either three or four imperfect tandem microtubule binding repeats that also form the core of tau filaments and contain hexapaptide motifs that are critical for tau aggregation. The tau microtubule-binding domain can also engage in direct interactions with detergents, fatty acids, or membranes, which can greatly facilitate tau aggregation and may also mediate some tau functions. Here, we show that the alternatively spliced second microtubule-binding repeat exhibits significantly different structural characteristics compared with the other three repeats in the context of the intact repeat domain. Most notably, the PHF6* hexapeptide motif located at the N-terminus of repeat 2 has a lower propensity to form strand-like structure than the corresponding PHF6 motif in repeat 3, and unlike PHF6 converts to partially helical structure in the micelle-bound state. Interestingly, the behavior of the Module-B motif, located at the beginning of repeat 4, resembles that of PHF6* rather than PHF6. Our observations, combined with previous results showing that PHF6* and Module-B are both less effective than PHF6 in nucleating tau aggregation, suggest a hierarchy in the efficacy of these motifs in nucleating tau aggregation that originates in differences in their intrinsic propensities for extended strand-like structure and the resistance of these propensities to changes in tau's environment.
© 2013 The Protein Society.

Entities:  

Keywords:  Alzheimer's; PHF6; PHF6*; amyloid; microtubule-binding domain; microtubule-binding repeat; paired helical filaments; protein aggregation; tau

Mesh:

Substances:

Year:  2013        PMID: 23740819      PMCID: PMC3832040          DOI: 10.1002/pro.2290

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  69 in total

1.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

2.  Conformational transition state is responsible for assembly of microtubule-binding domain of tau protein.

Authors:  Shuko Hiraoka; Tian-Ming Yao; Katsuhiko Minoura; Koji Tomoo; Miho Sumida; Taizo Taniguchi; Toshimasa Ishida
Journal:  Biochem Biophys Res Commun       Date:  2004-03-12       Impact factor: 3.575

Review 3.  Mutations causing neurodegenerative tauopathies.

Authors:  Michel Goedert; Ross Jakes
Journal:  Biochim Biophys Acta       Date:  2005-01-03

4.  Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau.

Authors:  Corinna Klein; Eva-Maria Kramer; Anne-Marie Cardine; Burkhardt Schraven; Roland Brandt; Jacqueline Trotter
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

5.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

6.  Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure.

Authors:  O Schweers; E Schönbrunn-Hanebeck; A Marx; E Mandelkow
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

7.  Binding of the three-repeat domain of tau to phospholipid membranes induces an aggregated-like state of the protein.

Authors:  Georg Künze; Patrick Barré; Holger A Scheidt; Lars Thomas; David Eliezer; Daniel Huster
Journal:  Biochim Biophys Acta       Date:  2012-04-06

8.  Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules.

Authors:  B Trinczek; J Biernat; K Baumann; E M Mandelkow; E Mandelkow
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

9.  A soluble oligomer of tau associated with fiber formation analyzed by NMR.

Authors:  Dylan W Peterson; Hongjun Zhou; Frederick W Dahlquist; John Lew
Journal:  Biochemistry       Date:  2008-06-18       Impact factor: 3.162

10.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

View more
  20 in total

1.  Tau binds to lipid membrane surfaces via short amphipathic helices located in its microtubule-binding repeats.

Authors:  Elka R Georgieva; Shifeng Xiao; Peter P Borbat; Jack H Freed; David Eliezer
Journal:  Biophys J       Date:  2014-09-16       Impact factor: 4.033

2.  Tau mutants bind tubulin heterodimers with enhanced affinity.

Authors:  Shana Elbaum-Garfinkle; Garrett Cobb; Jocelyn T Compton; Xiao-Han Li; Elizabeth Rhoades
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

3.  Sequence-independent recognition of the amyloid structural motif by GFP protein family.

Authors:  Sherry C S Xu; Josephine G LoRicco; Anthony C Bishop; Nathan A James; Welby H Huynh; Scott A McCallum; Nadia R Roan; George I Makhatadze
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-24       Impact factor: 11.205

4.  HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation.

Authors:  Hannah E R Baughman; Amanda F Clouser; Rachel E Klevit; Abhinav Nath
Journal:  J Biol Chem       Date:  2018-01-03       Impact factor: 5.157

5.  Glycan Determinants of Heparin-Tau Interaction.

Authors:  Jing Zhao; Isabelle Huvent; Guy Lippens; David Eliezer; Anqiang Zhang; Quanhong Li; Peter Tessier; Robert J Linhardt; Fuming Zhang; Chunyu Wang
Journal:  Biophys J       Date:  2017-03-14       Impact factor: 4.033

6.  Sequence-Dependent Backbone Dynamics of Intrinsically Disordered Proteins.

Authors:  Souvik Dey; Matthew MacAinsh; Huan-Xiang Zhou
Journal:  J Chem Theory Comput       Date:  2022-09-09       Impact factor: 6.578

7.  Pathogenic Tau Impairs Axon Initial Segment Plasticity and Excitability Homeostasis.

Authors:  Peter Dongmin Sohn; Cindy Tzu-Ling Huang; Rui Yan; Li Fan; Tara E Tracy; Carolina M Camargo; Kelly M Montgomery; Taylor Arhar; Sue-Ann Mok; Rebecca Freilich; Justin Baik; Manni He; Shiaoching Gong; Erik D Roberson; Celeste M Karch; Jason E Gestwicki; Ke Xu; Kenneth S Kosik; Li Gan
Journal:  Neuron       Date:  2019-09-18       Impact factor: 17.173

Review 8.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

9.  Fisetin inhibits tau aggregation by interacting with the protein and preventing the formation of β-strands.

Authors:  Shifeng Xiao; Yafei Lu; Qiuping Wu; Jiaying Yang; Jierui Chen; Suyue Zhong; David Eliezer; Qiulong Tan; Chengchen Wu
Journal:  Int J Biol Macromol       Date:  2021-03-01       Impact factor: 8.025

10.  Effects of Alzheimer's Disease-Related Proteins on the Chirality of Brain Endothelial Cells.

Authors:  Haokang Zhang; Jie Fan; Zhen Zhao; Chunyu Wang; Leo Q Wan
Journal:  Cell Mol Bioeng       Date:  2021-03-22       Impact factor: 3.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.